EB-OCT enables large-volume, microscopic-resolution imaging of lung tissue, providing detailed ILD-specific features non-invasively.
In a cohort of 15 patients with difficult-to-diagnose ILD, EB-OCT showed 100% agreement with final multidisciplinary diagnosis, including cases where TBLC was non-diagnostic.
Combining EB-OCT with TBLC and Envisia Genomic Classifier augmented diagnostic confidence and refined differential diagnoses consistently across independent multidisciplinary centers.
This pilot study supports EB-OCT as a promising complementary modality to existing ILD diagnostic tools, warranting multicenter validation for broader clinical adoption.
